ChemicalBook > CAS DataBase List > Avizakimab
Avizakimab
- Product Name
- Avizakimab
- CAS No.
- 2229685-51-0
- Chemical Name
- Avizakimab
- Synonyms
- Avizakimab;Avizakimab (anti-IL-21);Research Grade Avizakimab
- CBNumber
- CB78081161
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Avizakimab Property
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Avizakimab Chemical Properties,Usage,Production
Uses
Avizakimab (BOS161721) is a humanized IgG1 monoclonal antibody that targets interleukin-21[1].
References
[1] Hussaini A, et al. A Double-Blind, Phase I, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BOS161721 in Healthy Subjects. Clin Transl Sci. 2020 Mar;13(2):337-344. DOI:10.1111/cts.12715
Avizakimab Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Avizakimab Suppliers
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- 15817493340
- 981810490@qq.com
- Country
- China
- ProdList
- 1566
- Advantage
- 58
- Tel
- 027-65317797 15926423062
- Fax
- QQ:422450190
- 422450190@qq.com
- Country
- China
- ProdList
- 10308
- Advantage
- 58
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
- Country
- China
- ProdList
- 9868
- Advantage
- 58
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com
- Country
- China
- ProdList
- 6762
- Advantage
- 58
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com
- Country
- China
- ProdList
- 11973
- Advantage
- 58
- Tel
- 0731-13823398 15111215862
- 313359644@qq.com
- Country
- China
- ProdList
- 4161
- Advantage
- 58
- Tel
- 15002134094
- marketing@targetmol.cn
- Country
- China
- ProdList
- 29243
- Advantage
- 58
- Tel
- 17316404525 17316404525
- 209533805@qq.com
- Country
- China
- ProdList
- 9763
- Advantage
- 58
2229685-51-0, AvizakimabRelated Search:
Istiratumab
Ivicentamab
Bezlotoxumab
Berlimatoxumab
Petosemtamab
Astegolimab
Eblasakimab
Alomfilimab
Simridarlimab
Merpentan